Brainstorm Cell Therapeutics Inc.
USD1.00
+0.10 (+11.10%)
CEO
Chaim Lebovits
IPO Date
2003-10-07
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.90
Prev. Close
$0.90
Day Low
$0.90
Day High
$1.00
52W Low
$0.46
52W High
$1.32
Market Cap
$0.01B
Volume
0.02M
| 1.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 353.9% | -408.6% | -0.26 | 0.24 | -0.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 805.2% | -287.3% | -1.36 | 0.35 | -2.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -126.4% | -83.5% | 0.26 | 3.69 | -5.9 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -89.7% | -62.1% | 0.20 | 3.85 | -4.8 |
| 31 Dec 2019 | FY | 200.0% | 6353.3% | 190.2% | -355.9% | -0.19 | 0.19 | -4.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -278.1% | -124.2% | 0.00 | 1.65 | -5.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -84.2% | -43.4% | 0.00 | 1.74 | -15.0 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -50.3% | -46.3% | 0.00 | 12.09 | -9.5 |
| -0.5 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 27.4% | -152.6% | -0.06 | 0.06 | -0.9 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 47.9% | -113.1% | -0.10 | 0.18 | -0.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 38.4% | -80.2% | -0.24 | 0.21 | -0.7 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 38.3% | -162.3% | -0.09 | 0.04 | -1.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 44.7% | -133.7% | -0.14 | 0.05 | -1.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 72.0% | -44.7% | -0.27 | 0.50 | -2.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 61.3% | -101.6% | -0.20 | 0.18 | -3.5 |
| 31 Dec 2023 | Q4 | 80.8% | -1626.2% | 114.8% | -132.6% | -0.26 | 0.24 | -0.6 |